These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1613126)

  • 1. Influence of food on the absorption of beta-methyldigoxin.
    Tsutsumi K; Nakashima H; Kotegawa T; Nakano S
    J Clin Pharmacol; 1992 Feb; 32(2):157-62. PubMed ID: 1613126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological availability of digoxin and beta-methyl-digoxin administered in the fasting state or after meals].
    Hess T; Krähenbühl A; Luisier J; Weiss M
    Schweiz Med Wochenschr; 1981 Sep; 111(39):1434-40. PubMed ID: 7291961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs.
    Kuhlmann J; Rietbrock N; Schnieders B
    J Cardiovasc Pharmacol; 1979; 1(2):219-34. PubMed ID: 94391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a standard breakfast on digoxin absorption in normal subjects.
    Johnson BF; O'Grady J; Sabey GA; Bye C
    Clin Pharmacol Ther; 1978 Mar; 23(3):315-9. PubMed ID: 627138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and beta-methyldigoxin in rats.
    Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
    J Pharm Sci; 2003 Jul; 92(7):1455-63. PubMed ID: 12820149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of beta-methyldigoxin in subjects with normal and impaired renal function.
    Tsutsumi K; Nakashima H; Tateishi T; Imagawa M; Nakano S
    J Clin Pharmacol; 1993 Feb; 33(2):154-60. PubMed ID: 8440765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of medigoxin and digoxin in the control of atrial fibrillation.
    Coburn P; Kongola GM; Mawer GE
    Br J Clin Pharmacol; 1979 Jul; 8(1):53-8. PubMed ID: 552298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics of digitalis glycoside in childhood. Comparative study of the bioavailability of digoxin and beta methyldigoxin].
    Arrigo F; Consolo S; Barberi I; Melluso C
    Boll Soc Ital Cardiol; 1977; 22(3):293-303. PubMed ID: 617275
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of food on the oral absorption and bioavailability of moricizine.
    Pieniaszek HJ; Rakestraw DC; Schary WL; Williams RL
    J Clin Pharmacol; 1991 Sep; 31(9):792-5. PubMed ID: 1804860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin concentration in cerebrospinal fluid-a study carried out after 9 days of treatment of beta-methyldigoxin or beta-acetyldigoxin.
    Bonelli J; Rameis H; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):93-5. PubMed ID: 7228456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metildigoxin (beta-methyldigoxin) on congestive heart failure as evaluated by multiclinical double blind study.
    Kimura E; Sakuma A
    Jpn Heart J; 1980 Jan; 21(1):47-57. PubMed ID: 6988622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of medigoxin in outpatients.
    Smith WR; Rodgers EM; Nicholson PW; Humm RP; Gettins DA; Dobbs SM; Deshmukh AA
    Eur J Clin Pharmacol; 1981 Mar; 19(4):251-8. PubMed ID: 7286028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in metildigoxin pharmacokinetics in cirrhosis of the liver: a comparison with beta-acetyldigoxin.
    Rameis H; Woodcock B; Bonelli J; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):145-51. PubMed ID: 6715083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcium channel blockers on the pharmacokinetics of oral beta-methyldigoxin].
    Enomoto N; Yokota M; Sotobata I; Goto J; Ando K; Sobue I
    Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):781-7. PubMed ID: 3225495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver (author's transl)].
    Rameis H; Bonelli J; Waginger H; Hruby K
    Wien Klin Wochenschr; 1981 Oct; 93(18):572-6. PubMed ID: 7303703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variances in pharmacokinetic parameters due to assay methods for beta-methyldigoxin.
    Goto M; Suzuki A; Terashima T; Johno I; Kitazawa S
    J Pharmacobiodyn; 1987 May; 10(5):209-14. PubMed ID: 3305859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and beta-methyldigoxin in rats.
    Funakoshi S; Murakami T; Yumoto R; Kiribayashi Y; Takano M
    J Pharm Sci; 2005 Jun; 94(6):1196-203. PubMed ID: 15858844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of digoxin and beta-methyl-digoxin in patients with liver and gastro-intestinal diseases ].
    Hess T; Bütler A; Stucki P
    Wien Klin Wochenschr; 1982 May; 94(10):251-8. PubMed ID: 7123952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.